66758-051 : Topotecan 1 mg/ml Intravenous Injection
| NDC: | 66758-051 |
| Labeler: | Sandoz Inc |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Topotecan |
| Dosage Form: | Intravenous Injection |
| Application #: | NDA200199 |
| Rev. Date: |
NDC Package Codes:
- 66758-051-01: 1 VIAL, MULTI‑DOSE IN 1 CARTON (66758‑051‑01) > 1 ML IN 1 VIAL, MULTI‑DOSE
- 66758-051-03: 1 VIAL, MULTI‑DOSE IN 1 CARTON (66758‑051‑03) > 3 ML IN 1 VIAL, MULTI‑DOSE
- 66758-051-05: 1 VIAL, MULTI‑DOSE IN 1 CARTON (66758‑051‑05) > 4 ML IN 1 VIAL, MULTI‑DOSE
Active Ingredients:
- Topotecan Hydrochloride
Dosage Strength:
- 1 mg/mL
Pharmaceutical Classes:
- Topoisomerase Inhibitor [EPC]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0409-0302 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
- 0703-4714 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc.
- 16729-243 Topotecan 1 mg/ml Intravenous Injection by Accord Healthcare Inc.
- 25021-236 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Sagent Pharmaceuticals
- 50742-404 Topotecan 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Ingenus Pharmaceuticals, LLC
- 67457-662 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Mylan Institutional LLC
- 71288-127 Topotecan 4 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 66758-050Next: 66758-054 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.